ArticleCureus2025
A Case of Systemic Lupus Erythematosus With Sole Anti-phosphatidylserine/Prothrombin Complex Antibodies Complicated by Vertebral Artery Dissection.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebrovascular diseases commonly complicate systemic lupus erythematosus (SLE); however, vertebral artery dissection is rare. Although cerebrovascular diseases in SLE are often associated with antiphospholipid antibodies (aPL), such as lupus anticoagulant (LAC), anticardiolipin antibodies (aCL), and anti-β2 glycoprotein-I antibodies, reports of cases with sole positive anti-phosphatidylserine/prothrombin complex antibodies (aPS/PT) are also rare. Herein, we report the case of a 44-year-old woman with SLE who had sole positive aPS/PT results and presented with vertebral artery dissection. The patient, who had previously undergone bypass surgery of the right superficial temporal and middle cerebral arteries for moyamoya vessels, was found to have an asymptomatic left vertebral artery dissection during a follow-up examination. The patient also had a malar rash. Laboratory examination revealed hypocomplementemia and positive results for antinuclear and anti-Smith antibodies. LAC, aCL, and anti-β2 glycoprotein-I antibodies were negative; however, aPS/PT of immunoglobulin G was positive. The patient was diagnosed with SLE with sole positive aPS/PT result complicated by left vertebral artery dissection and moyamoya vessels. We initiated treatment with methylprednisolone pulse therapy, followed by oral prednisolone and intravenous cyclophosphamide. The patient's condition improved without sequelae. This case suggests that even though patients with SLE presenting with vascular complications lack LAC, aCL, and anti-β2 glycoprotein-I antibodies, other aPLs should be investigated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.